Industry Research Reports
Home > Reports > Medical Care > Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Industry: Medical Care
Published Date: 2024-04-16
Pages: 146 Pages
Report ld: 2683250
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Oncolytic Virus Therapy Market Size(US$)
CAGR 2024-2030
24.9%
Market Size,2030
USD 29
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 8 million
Market Forecast in 2030(Value)
US$ 29 million
CAGR
24.9%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 6 million in 2023 and is forecast to a readjusted size of US$ 29 million by 2030 with a CAGR of 24.9% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
MARKET SEGMENTATION
By Company
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Oncolytic Virus Therapy in global and regional level.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Oncolytic Virus Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncolytic Virus Therapy Market Size Estimates and Forecasts
2.2 Oncolytic Virus Therapy Market Size by Region: 2023 Versus 2030
2.2.1 Global Oncolytic Virus Therapy Revenue by Region: 2019-2024
2.2.2 Global Oncolytic Virus Therapy Revenue Forecast by Region (2025-2030)
2.2.3 Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2030)
3 Global Oncolytic Virus Therapy by Company
3.1 Global Oncolytic Virus Therapy Revenue by Company (2019-2024)
3.2 Global Oncolytic Virus Therapy Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Oncolytic Virus Therapy Companies around the World: Ranking by Revenue
3.3.2 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Oncolytic Virus Therapy Companies Headquarters & Product Type
3.4.1 Oncolytic Virus Therapy Companies Headquarters
3.4.2 Global Oncolytic Virus Therapy Companies Product & Service
3.4.3 Date of International Companies Enter into Oncolytic Virus Therapy Market
3.5 Global Oncolytic Virus Therapy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Amgen
4.1.1 Amgen Company Information
4.1.2 Amgen Description, Business Overview
4.1.3 Amgen Oncolytic Virus Therapy Products Offered
4.1.4 Amgen Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.1.5 Amgen Oncolytic Virus Therapy Revenue by Product in 2023
4.1.6 Amgen Oncolytic Virus Therapy Revenue by Application in 2023
4.1.7 Amgen Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.1.8 Amgen Recent Developments
4.2 Oncolytics Biotech
4.2.1 Oncolytics Biotech Company Information
4.2.2 Oncolytics Biotech Description, Business Overview
4.2.3 Oncolytics Biotech Oncolytic Virus Therapy Products Offered
4.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.2.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue by Product in 2023
4.2.6 Oncolytics Biotech Oncolytic Virus Therapy Revenue by Application in 2023
4.2.7 Oncolytics Biotech Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.2.8 Oncolytics Biotech Recent Developments
4.3 Viralytics
4.3.1 Viralytics Company Information
4.3.2 Viralytics Description, Business Overview
4.3.3 Viralytics Oncolytic Virus Therapy Products Offered
4.3.4 Viralytics Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.3.5 Viralytics Oncolytic Virus Therapy Revenue by Product in 2023
4.3.6 Viralytics Oncolytic Virus Therapy Revenue by Application in 2023
4.3.7 Viralytics Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.3.8 Viralytics Recent Developments
4.4 Transgene SA
4.4.1 Transgene SA Company Information
4.4.2 Transgene SA Description, Business Overview
4.4.3 Transgene SA Oncolytic Virus Therapy Products Offered
4.4.4 Transgene SA Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.4.5 Transgene SA Oncolytic Virus Therapy Revenue by Product in 2023
4.4.6 Transgene SA Oncolytic Virus Therapy Revenue by Application in 2023
4.4.7 Transgene SA Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.4.8 Transgene SA Recent Developments
4.5 Oncolys BioPharma
4.5.1 Oncolys BioPharma Company Information
4.5.2 Oncolys BioPharma Description, Business Overview
4.5.3 Oncolys BioPharma Oncolytic Virus Therapy Products Offered
4.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.5.5 Oncolys BioPharma Oncolytic Virus Therapy Revenue by Product in 2023
4.5.6 Oncolys BioPharma Oncolytic Virus Therapy Revenue by Application in 2023
4.5.7 Oncolys BioPharma Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.5.8 Oncolys BioPharma Recent Developments
4.6 Targovax
4.6.1 Targovax Company Information
4.6.2 Targovax Description, Business Overview
4.6.3 Targovax Oncolytic Virus Therapy Products Offered
4.6.4 Targovax Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.6.5 Targovax Oncolytic Virus Therapy Revenue by Product in 2023
4.6.6 Targovax Oncolytic Virus Therapy Revenue by Application in 2023
4.6.7 Targovax Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.6.8 Targovax Recent Development
4.7 PsiOxus Therapeutics
4.7.1 PsiOxus Therapeutics Company Information
4.7.2 PsiOxus Therapeutics Description, Business Overview
4.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Products Offered
4.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.7.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue by Product in 2023
4.7.6 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue by Application in 2023
4.7.7 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.7.8 PsiOxus Therapeutics Recent Development
4.8 SillaJen Biotherapeutics
4.8.1 SillaJen Biotherapeutics Company Information
4.8.2 SillaJen Biotherapeutics Description, Business Overview
4.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Products Offered
4.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.8.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue by Product in 2023
4.8.6 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue by Application in 2023
4.8.7 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.8.8 SillaJen Biotherapeutics Recent Development
4.9 Sorrento Therapeutics
4.9.1 Sorrento Therapeutics Company Information
4.9.2 Sorrento Therapeutics Description, Business Overview
4.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Products Offered
4.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.9.5 Sorrento Therapeutics Oncolytic Virus Therapy Revenue by Product in 2023
4.9.6 Sorrento Therapeutics Oncolytic Virus Therapy Revenue by Application in 2023
4.9.7 Sorrento Therapeutics Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.9.8 Sorrento Therapeutics Recent Development
4.10 Lokon Pharma
4.10.1 Lokon Pharma Company Information
4.10.2 Lokon Pharma Description, Business Overview
4.10.3 Lokon Pharma Oncolytic Virus Therapy Products Offered
4.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.10.5 Lokon Pharma Oncolytic Virus Therapy Revenue by Product in 2023
4.10.6 Lokon Pharma Oncolytic Virus Therapy Revenue by Application in 2023
4.10.7 Lokon Pharma Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.10.8 Lokon Pharma Recent Development
4.11 Genelux Corporation
4.11.1 Genelux Corporation Company Information
4.11.2 Genelux Corporation Description, Business Overview
4.11.3 Genelux Corporation Oncolytic Virus Therapy Products Offered
4.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.11.5 Genelux Corporation Oncolytic Virus Therapy Revenue by Product in 2023
4.11.6 Genelux Corporation Oncolytic Virus Therapy Revenue by Application in 2023
4.11.7 Genelux Corporation Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.11.8 Genelux Corporation Recent Development
4.12 Vyriad
4.12.1 Vyriad Company Information
4.12.2 Vyriad Description, Business Overview
4.12.3 Vyriad Oncolytic Virus Therapy Products Offered
4.12.4 Vyriad Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.12.5 Vyriad Oncolytic Virus Therapy Revenue by Product in 2023
4.12.6 Vyriad Oncolytic Virus Therapy Revenue by Application in 2023
4.12.7 Vyriad Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.12.8 Vyriad Recent Development
4.13 TILT Biotherapeutics
4.13.1 TILT Biotherapeutics Company Information
4.13.2 TILT Biotherapeutics Description, Business Overview
4.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Products Offered
4.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.13.5 TILT Biotherapeutics Oncolytic Virus Therapy Revenue by Product in 2023
4.13.6 TILT Biotherapeutics Oncolytic Virus Therapy Revenue by Application in 2023
4.13.7 TILT Biotherapeutics Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.13.8 TILT Biotherapeutics Recent Development
4.14 Cold Genesys
4.14.1 Cold Genesys Company Information
4.14.2 Cold Genesys Description, Business Overview
4.14.3 Cold Genesys Oncolytic Virus Therapy Products Offered
4.14.4 Cold Genesys Oncolytic Virus Therapy Revenue and Gross Margin (2019-2024)
4.14.5 Cold Genesys Oncolytic Virus Therapy Revenue by Product in 2023
4.14.6 Cold Genesys Oncolytic Virus Therapy Revenue by Application in 2023
4.14.7 Cold Genesys Oncolytic Virus Therapy Revenue by Geographic Area in 2023
4.14.8 Cold Genesys Recent Development
5 Breakdown Data by Type
5.1 Global Oncolytic Virus Therapy Revenue by Type (2019-2024)
5.2 Global Oncolytic Virus Therapy Revenue Forecast by Type (2025-2030)
5.3 Oncolytic Virus Therapy Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Oncolytic Virus Therapy Revenue by Application (2019-2024)
6.2 Global Oncolytic Virus Therapy Revenue Forecast by Application (2025-2030)
6.3 Oncolytic Virus Therapy Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Oncolytic Virus Therapy Market Size YoY Growth 2019-2030
7.2 North America Oncolytic Virus Therapy Market Facts & Figures by Country (2019-2030)
7.3 North America Oncolytic Virus Therapy Revenue by Type (2019-2024)
7.4 North America Oncolytic Virus Therapy Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Oncolytic Virus Therapy Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2019-2024)
9 Europe
9.1 Europe Oncolytic Virus Therapy Market Size YoY Growth 2019-2030
9.2 Europe Oncolytic Virus Therapy Market Facts & Figures by Country (2019-2030)
9.3 Europe Oncolytic Virus Therapy Revenue by Type (2019-2024)
9.4 Europe Oncolytic Virus Therapy Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Oncolytic Virus Therapy Market Size YoY Growth 2019-2030
10.2 Latin America Oncolytic Virus Therapy Market Facts & Figures by Country (2019-2030)
10.3 Latin America Oncolytic Virus Therapy Revenue by Type (2019-2024)
10.4 Latin America Oncolytic Virus Therapy Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Oncolytic Virus Therapy Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Oncolytic Virus Therapy Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Oncolytic Virus Therapy Revenue by Type (2019-2024)
11.4 Middle East and Africa Oncolytic Virus Therapy Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Oncolytic Virus Therapy Supply Chain Analysis
12.2 Oncolytic Virus Therapy Key Raw Materials and Upstream Suppliers
12.3 Oncolytic Virus Therapy Clients Analysis
12.4 Oncolytic Virus Therapy Sales Channel and Sales Model Analysis
12.4.1 Oncolytic Virus Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Oncolytic Virus Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Oncolytic Virus Therapy Distributors
13 Market Dynamics
13.1 Oncolytic Virus Therapy Industry Trends
13.2 Oncolytic Virus Therapy Market Drivers
13.3 Oncolytic Virus Therapy Market Challenges
13.4 Oncolytic Virus Therapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Companies of HSV-based Oncolytic Viruses
Table 3. Major Companies of Adenoviruses-based Oncolytic Viruses
Table 4. Major Companies of Vaccinia Virus-based Oncolytic Viruses
Table 5. Major Companies of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Major Companies of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2023 VS 2030
Table 9. Global Oncolytic Virus Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Oncolytic Virus Therapy Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 11. Oncolytic Virus Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 12. Oncolytic Virus Therapy Revenue Share by Company (2019-2024)
Table 13. Ranking of Global Top Oncolytic Virus Therapy Players by Revenue (US$ Million) in 2023
Table 14. Global Oncolytic Virus Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 15. Global Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
Table 16. Global Oncolytic Virus Therapy Companies Headquarters
Table 17. Global Oncolytic Virus Therapy Companies Product & Service
Table 18. Date of International Companies Enter into Oncolytic Virus Therapy Market
Table 19. Global Oncolytic Virus Therapy Mergers & Acquisitions, Expansion Plans
Table 20. Amgen Company Information
Table 21. Amgen Description and Business Overview
Table 22. Amgen Oncolytic Virus Therapy Product
Table 23. Amgen Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 24. Amgen Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 25. Amgen Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 26. Amgen Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 27. Amgen Recent Development
Table 28. Oncolytics Biotech Company Information
Table 29. Oncolytics Biotech Description and Business Overview
Table 30. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 31. Oncolytics Biotech Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 32. Oncolytics Biotech Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 33. Oncolytics Biotech Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 34. Oncolytics Biotech Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 35. Oncolytics Biotech Recent Development
Table 36. Viralytics Company Information
Table 37. Viralytics Description and Business Overview
Table 38. Viralytics Oncolytic Virus Therapy Product
Table 39. Viralytics Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 40. Viralytics Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 41. Viralytics Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 42. Viralytics Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 43. Viralytics Recent Development
Table 44. Transgene SA Company Information
Table 45. Transgene SA Description and Business Overview
Table 46. Transgene SA Oncolytic Virus Therapy Product
Table 47. Transgene SA Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. Transgene SA Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 49. Transgene SA Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 50. Transgene SA Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 51. Transgene SA Recent Development
Table 52. Oncolys BioPharma Company Information
Table 53. Oncolys BioPharma Description and Business Overview
Table 54. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 55. Oncolys BioPharma Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 56. Oncolys BioPharma Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 57. Oncolys BioPharma Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 58. Oncolys BioPharma Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 59. Oncolys BioPharma Recent Development
Table 60. Targovax Company Information
Table 61. Targovax Description and Business Overview
Table 62. Targovax Oncolytic Virus Therapy Product
Table 63. Targovax Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 64. Targovax Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 65. Targovax Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 66. Targovax Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 67. Targovax Recent Development
Table 68. PsiOxus Therapeutics Company Information
Table 69. PsiOxus Therapeutics Description and Business Overview
Table 70. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 71. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. PsiOxus Therapeutics Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 73. PsiOxus Therapeutics Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 74. PsiOxus Therapeutics Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 75. PsiOxus Therapeutics Recent Development
Table 76. SillaJen Biotherapeutics Company Information
Table 77. SillaJen Biotherapeutics Description and Business Overview
Table 78. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
Table 79. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. SillaJen Biotherapeutics Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 81. SillaJen Biotherapeutics Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 82. SillaJen Biotherapeutics Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 83. SillaJen Biotherapeutics Recent Development
Table 84. Sorrento Therapeutics Company Information
Table 85. Sorrento Therapeutics Description and Business Overview
Table 86. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 87. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. Sorrento Therapeutics Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 89. Sorrento Therapeutics Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 90. Sorrento Therapeutics Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 91. Sorrento Therapeutics Recent Development
Table 92. Lokon Pharma Company Information
Table 93. Lokon Pharma Description and Business Overview
Table 94. Lokon Pharma Oncolytic Virus Therapy Product
Table 95. Lokon Pharma Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Lokon Pharma Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 97. Lokon Pharma Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 98. Lokon Pharma Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 99. Lokon Pharma Recent Development
Table 100. Genelux Corporation Company Information
Table 101. Genelux Corporation Description and Business Overview
Table 102. Genelux Corporation Oncolytic Virus Therapy Product
Table 103. Genelux Corporation Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 104. Genelux Corporation Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 105. Genelux Corporation Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 106. Genelux Corporation Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 107. Genelux Corporation Recent Development
Table 108. Vyriad Company Information
Table 109. Vyriad Description and Business Overview
Table 110. Vyriad Oncolytic Virus Therapy Product
Table 111. Vyriad Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 112. Vyriad Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 113. Vyriad Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 114. Vyriad Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 115. Vyriad Recent Development
Table 116. TILT Biotherapeutics Company Information
Table 117. TILT Biotherapeutics Description and Business Overview
Table 118. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 119. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 120. TILT Biotherapeutics Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 121. TILT Biotherapeutics Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 122. TILT Biotherapeutics Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 123. TILT Biotherapeutics Recent Development
Table 124. Cold Genesys Company Information
Table 125. Cold Genesys Description and Business Overview
Table 126. Cold Genesys Oncolytic Virus Therapy Product
Table 127. Cold Genesys Oncolytic Virus Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 128. Cold Genesys Revenue Proportion of Oncolytic Virus Therapy by Product in 2023
Table 129. Cold Genesys Revenue Proportion of Oncolytic Virus Therapy by Application in 2023
Table 130. Cold Genesys Revenue Proportion of Oncolytic Virus Therapy by Geographic Area in 2023
Table 131. Cold Genesys Recent Development
Table 132. Global Oncolytic Virus Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 133. Global Oncolytic Virus Therapy Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 134. Global Oncolytic Virus Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 135. Global Oncolytic Virus Therapy Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 136. North America Oncolytic Virus Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 137. North America Oncolytic Virus Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 138. North America Oncolytic Virus Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 139. North America Oncolytic Virus Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 140. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2019-2030) & (US$ Million)
Table 141. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 142. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 143. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 144. Europe Oncolytic Virus Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 145. Europe Oncolytic Virus Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 146. Europe Oncolytic Virus Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 147. Europe Oncolytic Virus Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 148. Latin America Oncolytic Virus Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 149. Latin America Oncolytic Virus Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 150. Latin America Oncolytic Virus Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 151. Latin America Oncolytic Virus Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 152. Middle East and Africa Oncolytic Virus Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 153. Middle East and Africa Oncolytic Virus Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 154. Middle East and Africa Oncolytic Virus Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 155. Middle East and Africa Oncolytic Virus Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 156. Oncolytic Virus Therapy Key Raw Materials, Industry Status and Trend
Table 157. Oncolytic Virus Therapy Key Raw Materials and Upstream Suppliers
Table 158. Oncolytic Virus Therapy Clients Status and Trend
Table 159. Oncolytic Virus Therapy Typical Clients
Table 160. Oncolytic Virus Therapy Distributors
Table 161. Oncolytic Virus Therapy Market Trends
Table 162. Oncolytic Virus Therapy Market Drivers
Table 163. Oncolytic Virus Therapy Market Challenges
Table 164. Oncolytic Virus Therapy Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncolytic Virus Therapy Product Picture
Figure 2. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2023 & 2030
Figure 3. HSV-based Oncolytic Viruses Product Picture
Figure 4. Adenoviruses-based Oncolytic Viruses Product Picture
Figure 5. Vaccinia Virus-based Oncolytic Viruses Product Picture
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Product Picture
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Product Picture
Figure 8. Global Oncolytic Virus Therapy Revenue Market Share by Application in 2023 & 2030
Figure 9. Melanoma
Figure 10. Prostate Cancer
Figure 11. Breast Cancer
Figure 12. Ovarian Cancer
Figure 13. Others
Figure 14. Oncolytic Virus Therapy Report Years Considered
Figure 15. Global Oncolytic Virus Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oncolytic Virus Therapy Market Size 2019-2030 (US$ Million)
Figure 17. Global Oncolytic Virus Therapy Market Size Market Share by Region: 2023 Versus 2030
Figure 18. Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2030)
Figure 19. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oncolytic Virus Therapy Revenue Market Share Forecast by Type (2019-2030)
Figure 21. Global Oncolytic Virus Therapy Revenue Market Share Forecast by Application (2019-2030)
Figure 22. North America Oncolytic Virus Therapy Revenue 2019-2030 (US$ Million)
Figure 23. North America Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Figure 24. North America Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Figure 25. Asia-Pacific Oncolytic Virus Therapy Revenue 2019-2030 (US$ Million)
Figure 26. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Region (2019-2030)
Figure 27. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Figure 28. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Figure 29. Europe Oncolytic Virus Therapy Revenue Growth Rate 2019-2030 (US$ Million)
Figure 30. Europe Oncolytic Virus Therapy Revenue Market Share by Country (2019-2030)
Figure 31. Europe Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Figure 32. Europe Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Figure 33. Latin America Oncolytic Virus Therapy Revenue Growth Rate 2019-2030 (US$ Million)
Figure 34. Latin America Oncolytic Virus Therapy Revenue Market Share by Country (2019-2024)
Figure 35. Latin America Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Figure 36. Latin America Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Figure 37. Middle East and Africa Oncolytic Virus Therapy Revenue Growth Rate 2019-2030 (US$ Million)
Figure 38. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Country (2019-2030)
Figure 39. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Figure 40. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Figure 41. Oncolytic Virus Therapy Supply Chain (Upstream and Downstream Market)
Figure 42. Global Production Market Share of Oncolytic Virus Therapy Raw Materials by Region in 2023
Figure 43. Oncolytic Virus Therapy Distribution Channels
Figure 44. Global Oncolytic Virus Therapy Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 45. Global Oncolytic Virus Therapy Percentage 2019-2030: Online Sales VS Offline Sales
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Figure 49. Global Oncolytic Virus Therapy Percentage 2019-2030: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 24.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Oncolytic Virus Therapy in 2030?
Which companies rank high in the global Oncolytic Virus Therapy market?
What is the annual compound growth rate of the global Oncolytic Virus Therapy market size from 2024 to 2030?
What was the global market size of Oncolytic Virus Therapy in 2024?
Related Reports
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oncolytic Virus Therapy market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 232 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 67
USD 4250.00
(Single User License)
Global Oncolytic Virus Therapy Market Research Report 2026
The global Oncolytic Virus Therapy market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 99
USD 2900.00
(Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 232 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 73
USD 3950.00
(Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 77
USD 3950.00
(Single User License)
Global Oncolytic Virus Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oncolytic Virus Therapy market is projected to grow from US$ 106 million in 2024 to US$ 213 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 103
USD 4900.00
(Single User License)
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncolytic Virus Therapy market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 67
USD 4250.00
(Single User License)
Global Oncolytic Virus Therapy Market Research Report 2025
The global market for Oncolytic Virus Therapy was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 213 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published Date: 2025-08-13
Pages: 67
USD 2900.00
(Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million and is forecast to reach approximately US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 135
USD 5900.00
(Single User License)
Oncolytic Virus Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 117
USD 3950.00
(Single User License)
Global Oncolytic Virus Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oncolytic Virus Therapy market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 232 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 67
USD 4250.00 (Single User License)Global Oncolytic Virus Therapy Market Research Report 2026
The global Oncolytic Virus Therapy market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 99
USD 2900.00 (Single User License)Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 232 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 73
USD 3950.00 (Single User License)Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 77
USD 3950.00 (Single User License)Global Oncolytic Virus Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oncolytic Virus Therapy market is projected to grow from US$ 106 million in 2024 to US$ 213 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 103
USD 4900.00 (Single User License)Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncolytic Virus Therapy market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 67
USD 4250.00 (Single User License)Global Oncolytic Virus Therapy Market Research Report 2025
The global market for Oncolytic Virus Therapy was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 213 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published: 2025-08-13
Pages: 67
USD 2900.00 (Single User License)Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million and is forecast to reach approximately US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 135
USD 5900.00 (Single User License)Oncolytic Virus Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 117
USD 3950.00 (Single User License)Global Oncolytic Virus Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now